SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Peregrine Pharmaceuticals, Inc. (PPHM) and Health Management Associates, Inc. (HMA)
NEW YORK, Dec. 4, 2012 /PRNewswire/ --
Young Innovations, Inc.
Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (NasdaqGS: YDNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to an affiliate of Linden Capital Partners for $39.50 per share. Young Innovations stock traded above the offer price as recently as September 27, 2012.
Click here to learn more about the investigation: http://zlk.9nl.com/young-innovations-ydnt/, or call: 877-363-5972.
Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky is investigating potential claims on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities concerning possible breaches of fiduciary duty in connection with the disclosure of the discovery of major discrepancies in the treatment group of its Bavituxmab Phase II Second-Line Non-Small Cell Lung Cancer Trial.
For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/.
Health Management Associates, Inc.
Levi & Korsinsky is investigating potential claims on behalf of purchasers of Health Management Associates, Inc. (NYSE: HMA) securities concerning possible breaches of fiduciary duty.
For more information, click here: http://zlk.9nl.com/health-management-hma/.
On August 3, 2011, the Company announced that the U.S. Department of Health and Human Services (DHHS) had issued a subpoena requesting information concerning Health Management's physician referrals. As a result, shares in the Company's common stock dropped by $0.80, closing at $7.97 per share. Five months later, on January 9, 2012, an analyst from CRT Capital Group reported a lawsuit had been filed against the Company under Florida's Private Sector Whistleblower's Act by its former compliance director, Paul Meyer. Meyer alleges he was unlawfully terminated after reporting what he believed to be Medicare fraud, which also included fraudulent billing. Health Management's common stock fell yet again $0.53, dropping from $7.49 to $6.96 per share.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
SOURCE Levi & Korsinsky, LLP